Karin Moelling on Hooper Building and Barbara McClintock
  Karin Moelling     Biography    
Recorded: 06 Jun 2006

Yes, I like to stay at Hooper. The Hooper Building is, I don’t know 1930s or something, very old building. And it is very simple to stay there, but the style is, I just like it, it’s like a dormitory for young girls and it’s very noisy at nights and you have to use your foot to close the door and that doors unlocked for thirty years, at least since I came. The same defect with the lock and no man is ever using it so no body’s repairing it and I just like the simplicity of the style and the interaction and that’s why I always want to stay in Hooper. You look out of the window and you see the bay. So Barbara McClintock saw the spirit of the place, she lived there sometime also. So that’s, I just like it. I have a high respect of Barbara McClintock she did something very unique, but she lived in that house too.

Karin Moelling currently retired professor, still affiliated with the University of Zurich and the Max-Planck-Institute for Molecular Genetics in Berlin. She studied molecular biology at the University of Berkely, Califonia. She received her PhD at the Max-Planck-Institute for Virology at Tübingen in Germany. She did two post-doctoral research at the Robert Koch Institute in Berlin (1973-1975), and at the Institute of Virology, University Giessen. In 1977 she received her Habilitation at the University of Giessen in Biophysics on "Replication of retroviruses".

From 1976 till 1981 she was the Head of Independent Research Group at Max-Planck-Institute for Molecular Genetics in Berlin, Germany, on oncogenes, proto-oncogenes, cancer and HIV. In 1993 she became the Director of Institute of Medical Virology (IMV) and Full Professor at University of Zurich in Switzerland, she held this position till 2008. Between 2008-2009 she was Fellow of Institute of Advanced Study in Berlin and between 2008-2011 she became a Group Leader, Viruses and Cancer at University of Zurich.

Her research focus on retroviruses and cancer from molecular mechanisms to drug design. She is a Member of the European Molecular Biology Organization. She received several awards e.g. SwissAward in 2007, 4 prices: Czerny Price, Richtzenhain Price, Meyenburg Price and Ansman Price. She was Selected as Heisenberg Fellow in German Science Foundation.